US Patent Issued to Terran Biosciences on June 3 for "Salts and solid forms of (R)-1-(5-methoxy-1H-indol-1-yl)-N,N-dimethylpropan-2-amine" (New York, California Inventors)

ALEXANDRIA, Va., June 4 -- United States Patent no. 12,319,652, issued on June 3, was assigned to Terran Biosciences Inc. (Miami Beach, Fla.).

"Salts and solid forms of (R)-1-(5-methoxy-1H-indol-1-yl)-N,N-dimethylpropan-2-amine" was invented by Matthew Duncton (San Bruno, Calif.) and Samuel Clark (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure is directed to salt and solid forms of (R)-1-(5-METHOXY-1H-INDOL-1-YL)-N,N-DIMETHYLPROPAN-2-AMINE and methods of treating neurological disorder and/or a psychiatric disorder in a subject in need thereof."

The patent was filed on March 2, 2023, under Application No. 18/177,408.

*For further information, including images, charts and tabl...